Study of quality of life after new anal cancer diagnosis
Part of Cancer, Digestive system clinical trials.
This study looks at how people’s day-to-day functioning and quality of life change after an anal cancer diagnosis. It mainly enrolls adults recently diagnosed to understand outcomes early on.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be older than 18 years
- Have been diagnosed with anal squamous cell cancer within the last 2 months
- Be able to give informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how anal cancer tissue and samples change during and after treatment. Your participation may help doctors understand treatment response, especially for people with newly diagnosed or returning anal cancer.
This study looks at how women feel about their gynecological and sexual health after finishing radiation therapy for anal cancer. It may help doctors learn how to better support their patients after treatment.
This observational study follows people with anal cancer to understand how their quality of life changes after they receive standard chemoradiation therapy. It may help doctors better support patients with symptoms, recovery, and daily functioning over time.
This study looks at the overall health and well-being of people with colorectal or anal cancer. It may help doctors better understand how to support patients like you.
This trial studies how patients feel during and after radiation therapy for anal cancer. It uses questionnaires to understand symptoms and well-being, helping doctors improve care.
This study looks at how colorectal cancer and its treatment affect your daily life and well-being. It aims to help doctors better support patients like you during and after treatment.
Hear when a new Anal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.